WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004005486) MP21S AS MODIFIERS OF THE P21 PATHWAY AND METHODS OF USE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/005486    International Application No.:    PCT/US2003/021510
Publication Date: 15.01.2004 International Filing Date: 09.07.2003
IPC:
A61K 38/00 (2006.01), C07K 14/47 (2006.01), G01N 33/53 (2006.01), G01N 33/574 (2006.01)
Applicants: EXELIXIS, INC. [US/US]; P.O. Box 511, 170 Harbor Way, South San Francisco, CA 94083-0511 (US) (For All Designated States Except US).
FRANCIS-LANG, Helen [GB/US]; (US) (For US Only).
FRIEDMAN, Lori [US/US]; (US) (For US Only).
KIDD, Thomas [GB/US]; (US) (For US Only).
ROCHE, Siobhan [IE/IE]; (IE) (For US Only).
JOO, Daniel, M. [US/US]; (US) (For US Only).
LICKTEIG, Kim [US/US]; (US) (For US Only).
AMUNDSEN, Craig, D. [US/US]; (US) (For US Only).
HAI, Bing [CN/US]; (US) (For US Only).
ZHANG, HaiGuang [US/US]; (US) (For US Only).
ADAMKEWICZ, Joanne, I. [US/US]; (US) (For US Only).
HAMMONDS, Glenn, R., Jr. [US/US]; (US) (For US Only)
Inventors: FRANCIS-LANG, Helen; (US).
FRIEDMAN, Lori; (US).
KIDD, Thomas; (US).
ROCHE, Siobhan; (IE).
JOO, Daniel, M.; (US).
LICKTEIG, Kim; (US).
AMUNDSEN, Craig, D.; (US).
HAI, Bing; (US).
ZHANG, HaiGuang; (US).
ADAMKEWICZ, Joanne, I.; (US).
HAMMONDS, Glenn, R., Jr.; (US)
Agent: SHAYESTEH, Laleh; Exelixis, Inc., P. O. Box 511, 170 Harbor Way, South San Francisco, CA 94083-0511 (US)
Priority Data:
60/394,795 10.07.2002 US
60/401,739 07.08.2002 US
60/411,010 16.09.2002 US
60/437,158 30.12.2002 US
Title (EN) MP21S AS MODIFIERS OF THE P21 PATHWAY AND METHODS OF USE
(FR) GENES MP21 UTILISES COMME MODIFICATEURS DE LA VOIE P21 ET LEURS PROCEDES D'UTILISATION
Abstract: front page image
(EN)Human MP21 genes are identified as modulators of the p21 pathway, and thus are therapeutic targets for disorders associated with defective p21 function. Methods for identifying modulators of p21, comprising screening for agents that modulate the activity of MP21 are provided.
(FR)Les gènes humains MP21 sont identifiés comme modulateurs de la voie p21 et ils constituent par conséquent des cibles thérapeutiques pour les troubles associés à une fonction p21 défectueuse. Cette invention concerne également des procédés servant à identifier des modulateurs de p21, qui consistent à effectuer le criblage d'agents qui modulent l'activité du gène MP21. .
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)